Dec 29, 2025
What’s Going On With WORK Medical Technology Group Stock Today?

Shares of WORK Medical Technology Group (NASDAQ:WOK) are trading higher Monday after the medical devices company received manufacturing approval for one of its AI-powered products. WORK Medical Tech Gr stock is surging to new heights today. What’s fueling WOK momentum? What…

Dec 29, 2025
What’s Behind The Rise In Society Pass Stock Today?

Shares of Society Pass Incorporated (NASDAQ:SOPA) are rising Monday after the e-commerce company announced the launch of a live commerce digital retail advertising platform in Thailand. Society Pass shares are climbing with conviction. What’s behind SOPA gains? What To Know: The…

Dec 29, 2025
Genmab Prunes Pipeline, Sharpens Focus On Late-Stage Cancer Assets

Genmab A/S (NASDAQ:GMAB) on Monday said it will discontinue further clinical development of acasunlimab. The decision was made as part of Genmab’s strategic focus on the most value‑creating opportunities in its late‑stage portfolio and following a thorough assessment of the…

Dec 29, 2025
Praxis Stock Surges On FDA Breakthrough Status For Essential Tremor Drug

Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock rose Monday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for ulixacaltamide for essential tremor (ET). Essential Tremor is the most common movement disorder, affecting roughly seven million people…

Dec 29, 2025
Tonix Unveils Once-Yearly Lyme Prevention Antibody, Eyes FDA Talks In 2026

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) on Monday announced program updates on TNX-4800 (formerly known as mAb 2217LS), a long-acting human monoclonal antibody (mAb) that targets the outer surface protein A (OspA) of Borrelia burgdorferi, the causative agent of Lyme disease…

Dec 29, 2025
Why Is Theriva Biologics Stock Gaining Monday?

Theriva Biologics, Inc. (NYSE:TOVX) stock rose on Monday, with a session volume of 114.18 million compared to the average volume of 15.61 million, as per data from Benzinga Pro. The company received Scientific Advice from the Committee for Medicinal Products…

Dec 29, 2025
Novo Nordisk Halves Wegovy Prices In China Ahead Of Generic Threat

Novo Nordisk A/S (NYSE:NVO) has reportedly slashed list prices for its obesity drug Wegovy by about 50% in parts of China, signaling a defensive move ahead of rising generic competition. Citing local print media, Bloomberg noted on Monday that prices…